| Literature DB >> 25043139 |
T Wester1, H Borg, H Naji, P Stenström, G Westbacke, H E Lilja.
Abstract
BACKGROUND: Serial transverse enteroplasty (STEP) was first described in 2003 as a method for lengthening and tapering of the bowel in short bowel syndrome. The aim of this multicentre study was to review the outcome of a Swedish cohort of children who underwent STEP.Entities:
Mesh:
Year: 2014 PMID: 25043139 PMCID: PMC4282069 DOI: 10.1002/bjs.9583
Source DB: PubMed Journal: Br J Surg ISSN: 0007-1323 Impact factor: 6.939
Fig 1In serial transverse enteroplasty, staplers are fired from alternating sides perpendicular to the direction of the bowel
Outcomes after serial transverse enteroplasty
| No. of patients | |
|---|---|
| Follow-up after STEP (months) ( | 37·2 (3·0–87·5) |
| Follow-up after re-STEP (months) ( | 19·7 (17·5–51·6) |
| Enteral autonomy | 7 of 12 |
| After STEP | 5 of 8 |
| After re-STEP | 2 of 4 |
| Time to enteral autonomy (months) ( | 19·5 (2·3–42·9) |
| Ratio of enteral/total caloric intake ( | 0·22–0·62 |
| Septicaemia with positive blood culture after STEP/re-STEP | 10 of 12 |
| Small bowel transplantation | 0 of 12 |
| Death | 0 of 12 |
Unless indicated otherwise
values are median (range). STEP, serial transverse enteroplasty.
P = 0.679 versus after STEP (χ2 test).
Bilirubin and liver enzymes before serial transverse enteroplasty and at follow-up
| Before STEP | At follow-up | ||
|---|---|---|---|
| Bilirubin (mmol/l) | 10·5 (2·7–242·0) | 3·5 (2·0–15·0) | 0·014 |
| AST (mmol/l) | 1·07 (0·37–6·60) | 0·64 (0·33–1·30) | 0·008 |
| ALT (mmol/l) | 1·0 (0·19–3·40) | 0·51 (0·17–1·70) | 0·050 |
Values are median (range). STEP, serial transverse enteroplasty; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
Wilcoxon signed-rank test.
Summary of published outcomes after serial transverse enteroplasty
| Reference | Year | Study location | Follow-up | Enteral autonomy (%) | Small bowel transplantation | Death | |
|---|---|---|---|---|---|---|---|
| Jones | 2013 | International STEP Data Registry | 97 | Median 21 months | 47 | 5 | 11 |
| Wales | 2007 | Toronto | 14 | Mean 23 months | 88 | 2 | 3 |
| Ching | 2009 | Boston | 16 | Median 23 months | 38 | 2 | 0 |
| Oliveira | 2012 | Toronto | 12 | > 5 years | 88 | 2 | 2 |
| Pakarinen | 2013 | Helsinki | 7 | Median 6·9 years | 86 | 0 | 1 |
| Javid | 2013 | Seattle | 16 | Median 26 months | 60 | 2 | 2 |
| Present study | 2014 | Sweden | 12 | Median 37·2 months | 58 | 0 | 0 |
A total of 111 patients were included in the registry, but there were adequate data for analysis on only 97. STEP, serial transverse enteroplasty.